Overview
Adpharma is a Polish pharmaceutical and biotechnology company with 40 years of experience, focusing on the development of prescription and over-the-counter medications, dietary supplements, dermocosmetics, and medical devices. The company offers high-quality therapeutic products addressing chronic diseases across several therapeutic areas and holds 256 patents in the pharmaceutical field. Adpharma's products are available in numerous markets worldwide, with an extensive portfolio of approximately 900 items.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2006-06-23. Active
45 1240 6292 1111 0011 0088 7515- 65 1240 6292 1111 0010 6168 9940
- 94 1240 6292 1111 0011 1466 7714
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company. In the case of a one-person management board, one member of the management board or a commercial proxy is authorized to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Małgorzata Adamkiewicz (60)  | Beneficjent posiada pośrednio 52,5% udziałów, poprzez adamed pharma s.a. która posiada 100% udziałów i głosów w adpharma sp. z o.o. |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| NOYO Pharmsp. z o.o. | $14,944,500.25 | noyopharm.com | |
| APIS Farmacjasp. z o.o. | $14,614,704.02 | apisapteka.pl | |
| Farmjugsp. z o.o. | $14,506,326.49 | farmjug.pl | |
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | |
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | |
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | |
| Sendpol24sp. z o.o. | $2,678,602.68 | sendpol24.pl | |
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | |
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | |
| Mediatessp. z o.o. | $1,373,118.20 | mediates.pl |
Change history
| Date | Event |
|---|---|
| 2019-02-27 | Address change (Ul. Mariana Adamkiewicza 6, 05-152, Pieńków 148 → Ul. Mariana Adamkiewicza 6, 05-152, Pieńków) |
| 2018-08-31 | Address change (05-152, Pieńków 148 → Ul. Mariana Adamkiewicza 6, 05-152, Pieńków 148) |
| 2015-10-28 | PKD change (Removed: 24.4, 25.24.Z, 51.46.Z, 52.32.Z, 74.14, 74.84.B; Added: 21.2, 46.46.Z, 70.22, 74.87.B) |
| 2013-11-19 | PKD change (Added: 47.73.Z, 47.74.Z, 47.75.Z) |
| 2006-09-25 | Address change (Królewska 27, 00-060, Warszawa → 05-152, Pieńków 148) |
FAQ
Last updated: 2026-04-13